John Chung
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
- Oncology top 10%
- Cancer-related Molecular Pathways
Papers in
-
- Thyroid Cancer Diagnosis and Treatment 7
-
- Neuroblastoma Research and Treatments 3
- Co-authors
- Johannes W. A. Smit (7 shared papers)Young Kee Shong (7 shared papers)Marcia S. Brose (7 shared papers)Steven I. Sherman (6 shared papers)Martin Schlumberger (6 shared papers)Christopher M. Nutting (6 shared papers)Christian Kappeler (5 shared papers)Barbara Jarząb (4 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)The Journal of Urology (1 paper)Clinical and Translational Science (1 paper)Intensive Care Medicine (1 paper)The Lancet (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
John Chung
14 papers receiving 1.6k citations
John Chung's Hit Papers
Peers
Comparison fields: 5 of 74
- Endocrinology, Diabetes and Metabolism 1.1k
- Oncology 380
- Anatomy 14
- Cancer Research 103
- Pathology and Forensic Medicine 104
Countries citing papers authored by John Chung
This map shows the geographic impact of John Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Chung more than expected).
Fields of papers citing papers by John Chung
This network shows the impact of papers produced by John Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Chung. The network helps show where John Chung may publish in the future.
Co-authors
The 25 scholars most cited alongside John Chung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial Hit paper breakdown → | 2014 | 1171 |
| 2 | 2011 | 77 | |
| 3 | 2013 | 61 | |
| 4 | 2019 | 51 | |
| 5 | 2015 | 47 | |
| 6 | Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2. | 2004 | 46 |
| 7 | 2013 | 41 | |
| 8 | 2014 | 27 | |
| 9 | 2009 | 21 | |
| 10 | 2003 | 19 | |
| 11 | 2018 | 13 | |
| 12 | 2020 | 6 | |
| 13 | 2014 | 4 | |
| 14 | 2023 | 3 |
About John Chung
John Chung is a scholar working on Endocrinology, Diabetes and Metabolism, Neurology, Molecular Biology, Oncology and Nephrology, having authored 14 papers that have together received 1.6k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (7 papers), Neuroblastoma Research and Treatments (3 papers), Cancer therapeutics and mechanisms (2 papers), Urinary Bladder and Prostate Research (1 paper), Lung Cancer Research Studies (1 paper), Lung Cancer Treatments and Mutations (1 paper), Acute Kidney Injury Research (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.1k citations), Oncology (380 citations), Anatomy (14 citations), Cancer Research (103 citations) and Pathology and Forensic Medicine (104 citations). John Chung has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Johannes W. A. Smit, Young Kee Shong, Marcia S. Brose, Steven I. Sherman, Martin Schlumberger, Christopher M. Nutting, Christian Kappeler, Barbara Jarząb, Christelle de la Fouchardière and Rossella Elisei. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology, Clinical and Translational Science, Intensive Care Medicine and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.